Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
US7208162B2 · kind B2 · utility
22Cited by
2References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 3, 2001 |
| Grant date | Apr 24, 2007 |
| Priority date | — |
| Expiry date | Dec 29, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutically effective anti-viral compositions, useful especially against respiratory diseases caused or mediated by respiratory syncytial virus (RSV) are disclosed, wherein said compositions comprise at least one anti-RSV antibody, including high affinity antibodies, and an additional anti-inflammatory agent, especially corticosteroids, as well as anti-inflammatory antibodies, especially anti-interleukin-6. Also disclosed are methods of using such compositions to treat and/or prevent respiratory diseases. Such compositions may optionally contain other non-antibody anti-viral agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.